|
Histology, degree of differentiation and TNM stage at the time of diagnosis of the primary tumor. |
||
| Histology |
Number of patients (n:60) |
Percentage |
|
|
||
| Serous cystadenocarcinoma |
38 |
63,3% |
| Mucinous adenocarcinoma |
8 |
13,4% |
| Mixed |
4 |
6,7% |
| Clear cell |
3 |
5% |
| Endometrioid |
2 |
3,4% |
| Unknown |
5 |
8,4% |
| Degree of differentiation |
||
| G1 |
16 |
26,7% |
| G2 |
18 |
30% |
| G3 |
26 |
43,3% |
| TNM stage |
||
| I |
8 |
13,3% |
| II |
18 |
30% |
| III |
22 |
36,7% |
| IV |
12 |
20% |
Barbetakis et al. BMC Palliative Care 2004 3:4 doi:10.1186/1472-684X-3-4 |
||